147 related articles for article (PubMed ID: 12437663)
1. Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia.
Zeng W; Maciejewski JP; Chen G; Risitano AM; Kirby M; Kajigaya S; Young NS
Br J Haematol; 2002 Dec; 119(3):803-9. PubMed ID: 12437663
[TBL] [Abstract][Full Text] [Related]
2. Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes.
Zhang HF; Huang ZD; Wu XR; Li Q; Yu ZF
Life Sci; 2017 Nov; 189():71-75. PubMed ID: 28935248
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA).
Li X; Xu F; He Q; Wu L; Zhang Z; Chang C
Intern Med; 2010; 49(14):1349-55. PubMed ID: 20647647
[TBL] [Abstract][Full Text] [Related]
4. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
Risitano AM; Maciejewski JP; Green S; Plasilova M; Zeng W; Young NS
Lancet; 2004 Jul 24-30; 364(9431):355-64. PubMed ID: 15276395
[TBL] [Abstract][Full Text] [Related]
5. Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases.
Plasilova M; Risitano A; Maciejewski JP
Hematology; 2003 Jun; 8(3):173-81. PubMed ID: 12745651
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of Lymphocyte Subsets in Peripheral Blood of Patients with Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome].
Lv YF; Yan ZY; Chen NY; Wu JH; Liu B; Wang GL; Wang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1505-1510. PubMed ID: 27784383
[TBL] [Abstract][Full Text] [Related]
7. Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes.
Fujii S; Shimizu K; Klimek V; Geller MD; Nimer SD; Dhodapkar MV
Br J Haematol; 2003 Aug; 122(4):617-22. PubMed ID: 12899717
[TBL] [Abstract][Full Text] [Related]
8. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M
Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953
[TBL] [Abstract][Full Text] [Related]
9. [Changes and clinical significance of CD8(+) T cell subset in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia].
Zhang JY; Xu HZ; Yin DM; Feng XM; Sui XH; Cui B; Ma CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):203-8. PubMed ID: 23484720
[TBL] [Abstract][Full Text] [Related]
10. [Changes of HLA-DR15 and immunoglobulin, T lymphocyte subsets in patients with aplastic anemia, myelodysplastic syndrome and their significance].
Cui JX; Pei MF; Zhang GS; Xu M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):111-5. PubMed ID: 20137129
[TBL] [Abstract][Full Text] [Related]
11. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia.
Kook H; Zeng W; Guibin C; Kirby M; Young NS; Maciejewski JP
Exp Hematol; 2001 Nov; 29(11):1270-7. PubMed ID: 11698122
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones.
Maciejewski JP; O'Keefe C; Gondek L; Tiu R
Folia Histochem Cytobiol; 2007; 45(1):5-14. PubMed ID: 17378239
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure.
Maciejewski JP; Hibbs JR; Anderson S; Katevas P; Young NS
Exp Hematol; 1994 Oct; 22(11):1102-10. PubMed ID: 7925777
[TBL] [Abstract][Full Text] [Related]
14. Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome.
Wlodarski MW; Gondek LP; Nearman ZP; Plasilova M; Kalaycio M; Hsi ED; Maciejewski JP
Blood; 2006 Oct; 108(8):2632-41. PubMed ID: 16614248
[TBL] [Abstract][Full Text] [Related]
15. Polarization of natural killer T cells towards an NKT2 subpopulation occurs after stimulation with alpha-galactosylceramide and rhG-CSF in aplastic anemia.
Wang Y; Hu X; Guo C; Zhang Q; Peng J; Zhang J; Li L; Zhang T; Xu C
Acta Haematol; 2008; 119(3):178-86. PubMed ID: 18535366
[TBL] [Abstract][Full Text] [Related]
16. T-cell receptor beta chain variability in bone marrow and peripheral blood in severe acquired aplastic anemia.
Manz CY; Dietrich PY; Schnuriger V; Nissen C; Wodnar-Filipowicz A
Blood Cells Mol Dis; 1997; 23(1):110-22. PubMed ID: 9215756
[TBL] [Abstract][Full Text] [Related]
17. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
Immunology; 2000 Feb; 99(2):229-34. PubMed ID: 10692041
[TBL] [Abstract][Full Text] [Related]
18. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cells.
Gansuvd B; Hubbard WJ; Hutchings A; Thomas FT; Goodwin J; Wilson SB; Exley MA; Thomas JM
J Immunol; 2003 Sep; 171(6):2904-11. PubMed ID: 12960313
[TBL] [Abstract][Full Text] [Related]
20. Comparison of immune manifestations between refractory cytopenia of childhood and aplastic anemia in children: A single-center retrospective study.
Wu J; Cheng Y; Zhang L
Leuk Res; 2015 Dec; 39(12):1347-52. PubMed ID: 26427728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
